Will discuss the evidence for the adverse biological phenotype of young-onset type 2 diabetes, its clinical implications and strategies to improve care in this young subgroup. The delegates will get a better understanding of this young condition and the salient aspects of care that should be considered in managing a young adult with type 2 diabetes.